Search Orphan Drug Designations and Approvals
-
Generic Name: | cinacalcet |
---|---|
Date Designated: | 09/07/2016 |
Orphan Designation: | Treatment of secondary hyperparathyroidism (HPT) in pediatric patients with chronic kidney disease receiving dialysis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Amgen, Inc. One Amgen Center Drive Bldg 17, 1A-4-4, Mail Stop 17-1-B Thousand Oaks, California 91320 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-